Iris Dirven - Vrije Universiteit Brussel, Universitair Ziekenhuis Brussel (UZ Brussel)

基本信息

浏览量：2

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 31 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

1132P Regorafenib in Caucasian Patients with Pretreated Advanced KIT-mutant Melanoma: A Dual Center Case Series

I. Dirven,E. De Vita, M. Vounckx, J.I. Kessels,M. Mandalà,B. Neyns

Annals of Oncology（2024）

引用0浏览0引用

Emotional Distress, Cognitive Complaints, and Care Needs among Advanced Cancer Survivors Treated with Immune Checkpoint Blockade: A Mixed-Method Study

Nathalie Vanlaer,Iris Dirven,Bart Neyns,Anne Rogiers

CANCERS（2024）

引用0浏览0WOS引用

OS03.5.A A PHASE I CLINICAL TRIAL ON THE INTRACRANIAL ADMINISTRATION OF AUTOLOGOUS CD1C(BDCA-1)+ /CD141(BDCA-3)+ MYELOID DENDRITIC CELLS IN COMBINATION WITH IPILIMUMAB AND NIVOLUMAB IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA

J Duerinck, L Lescrauwaet,I Dirven, J Del’haye, M Cammaert,W Geens,X Geeraerts, L Stevens, S Brock,M Kockx,H Everaert, a Vanbinst,S Tuyaerts,B Neyns

Neuro-Oncologyno. Supplement_5 (2024)

引用0浏览0引用

Regorafenib Combined with BRAF-/MEK-inhibitors for the Treatment of Refractory Melanoma Brain Metastases

Iris Dirven, Eden Pierre, An-Sofie Vander Mijnsbrugge,Manon Vounckx, Jolien I. Kessels,Bart Neyns

CANCERSno. 23 (2024)

引用0浏览0WOS引用

Successful Treatment with Dabrafenib/Trametinib of a Malignantly Transformed and Metastasized BRAF V600E Mutant Pleiomorphic Xanthoastrocytoma: A Case Report and Review of the Literature

Elle Vermeulen,An-Sofie Vander Mijnsbrugge,Stefanie Brock,Freya Vaeyens,Iris Dirven, Abdulhamid Cicek, William Marcelis,Samuel Klein,Michael Bruneau,Bart Neyns,Johnny Duerinck

Case Reports in Oncologyno. 1 (2024): 10-16

引用1浏览0WOS引用

Intratumoral Administration of the Immunologic Adjuvant AS01B in Combination with Autologous CD1c (BDCA-1)+/CD141 (BDCA-3)+ Myeloid Dendritic Cells Plus Ipilimumab and Intravenous Nivolumab in Patients with Refractory Advanced Melanoma

Jens Tijtgat,Xenia Geeraerts,Anais Boisson,Latoya Stevens,Manon Vounckx,Iris Dirven,Julia Katharina Schwarze,Steven Raeymaeckers,Ramses Forsyth,Ivan Van Riet,Sandra Tuyaerts,Karen Willard-Gallo,Bart Neyns

JOURNAL FOR IMMUNOTHERAPY OF CANCERno. 1 (2024)

引用1浏览0WOS引用

OS03.4.A REPEATED INTRACRANIAL ADMINISTRATION OF ANTI-PD-1 ALONE OR IN COMBINATION WITH ANTI-CTLA-4 IMMUNE CHECKPOINT-BLOCKING MONOCLONAL ANTIBODIES IN PATIENTS WITH RECURRENT HIGH-GRADE GLIOMA

L Lescrauwaet,I Dirven, J Del’haye,W Geens,X Geeraerts, L Stevens, S Brock,M Kockx, L Seynaeve,H Everaert, a Vanbinst,S Tuyaerts,B Neyns,J Duerinck

Neuro-Oncologyno. Supplement_5 (2024)

引用0浏览0引用

Intracranial Administration of Anti-Pd-1 and Anti-Ctla-4 Immune Checkpoint-Blocking Monoclonal Antibodies in Patients with Recurrent High-Grade Glioma

L. Lescrauwaet,I Dirven, J. Del'haye,W. Geens,X. Geeraerts,L. Stevens,S. Brock,M. Kockx, L. Seynaeve,H. Everaert,A. Vanbinst,S. Tuyaerts,B. Neyns,J. Duerinck

NEURO-ONCOLOGY（2024）

引用0浏览0WOS引用

Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAFV600/NRASQ61 Wild-Type Melanoma (Tramel-Wt)

Gil Awada,Iris Dirven,Julia Katharina Schwarze,Jens Tijtgat,Giuseppe Fasolino,Mark Kockx,Bart Neyns

JCO Precision Oncology (2024)

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn